Table 1.
Anthropometric and clinical measurements of the study population stratified by gender.
| Variable | Total (n = 300) |
Men (n = 69) |
Women (n = 231) |
P value |
|---|---|---|---|---|
| WC (cm) | 95.99 ± 15.61 | 85.17 ± 13.93 | 99.22 ± 14.63 | <0.001 |
| Abdominal obesity | ||||
| Yes | 231 (77.0%) | 18 (26.1%) | 213 (92.2%) | <0.001 |
| No | 69 (23.0%) | 51 (73.9%) | 18 (7.8%) | |
| WHR | 0.94 ± 0.20 | 0.71 ± 0.06 | 1.00 ± 0.18 | <0.001 |
| SBP (mmHg) | 122.8 ± 16.16 | 127 ± 12.04 | 121.6 ± 17.02 | 0.015 |
| DBP (mmHg) | 84.5 ± 13.83 | 88.26 ± 11.75 | 83.38 ± 14.23 | 0.001 |
| Elevated BP | ||||
| Yes | 57 (19.0%) | 21 (30.4%) | 36 (15.6%) | 0.008 |
| No | 243 (81.0%) | 48 (69.6%) | 195 (84.4%) | |
| Age (years) | 56.21 ± 12.12 | 52.83 ± 10.85 | 57.22 ± 12.32 | 0.008 |
| ≤40 years | 33 (11.0%) | 12 (17.4%) | 21 (9.1%) | 0.077 |
| >40 years | 267 (89.0%) | 57 (82.6%) | 210 (90.9%) | |
| FPG (Mean ± SD) | 7.94 ± 2.81 | 8.07 ± 2.76 | 7.9 ± 2.83 | 0.653 |
| Uncontrolled diabetes (%) | 231 (77.0%) | 51 (73.9%) | 180 (77.9%) | 0.516 |
| IFG (%) | 69/231 (29.9%) | 18/51 (35.3%) | 51/180 (28.3%) | 0.387 |
| Hyperglycaemia (%) | 162/231 (70.1%) | 33 (47.8%) | 129/180 (71.7%) | |
| Duration (years) | 5.23 ± 5.00 | 6.37 ± 4.9 | 4.88 ± 4.97 | 0.030 |
| ≤5 years | 198 (66.0%) | 39 (56.5%) | 159 (68.8%) | 0.062 |
| >5 years | 102 (34.0%) | 30 (43.5%) | 72 (31.2%) |
IFG: impaired fasting glycaemia.